TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $445,668 | -78.6% | 88,712 | -62.8% | 0.00% | -100.0% |
| Q2 2023 | $2,085,215 | -25.7% | 238,364 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $2,807,243 | +278950.0% | 237,111 | +139.7% | 0.00% | – |
| Q4 2022 | $1,006 | -99.5% | 98,940 | +197.0% | 0.00% | – |
| Q3 2022 | $196,000 | – | 33,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $67,778 | 7.80% |
| ACUTA CAPITAL PARTNERS, LLC | 1,100,000 | $11,198,000 | 6.89% |
| VR Adviser, LLC | 3,707,891 | $37,746,330 | 6.36% |
| Fairmount Funds Management LLC | 2,040,000 | $20,767,200 | 3.29% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $7,271,421 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 700,000 | $7,126,000 | 2.04% |
| Ikarian Capital, LLC | 737,319 | $7,505,908 | 1.81% |
| CROSSPOINT FINANCIAL, LLC | 15,054 | $153,250 | 1.69% |
| Orbimed Advisors | 7,619,135 | $77,562,794 | 1.48% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,448,275 | $35,103,440 | 1.47% |